Showing results (181-190 of 818) with videos related to
Sort By:
Pageof 82
Journal of Neurology, Neurosurgery, and Psychiatry|July 1, 1988
Botulinum toxin in spasmodic torticollisR Stell, P D Thompson, C D MarsdenNeuropharmacology|January 1, 1985
Comparison of the effects of benzodiazepines and other anticonvulsant drugs on synthesis and utilization of 5-HT in mouse brainJ A Pratt, P Jenner, C D MarsdenOtolaryngologic Clinics of North America|February 19, 2021
The Role of Mohs Surgery in Cutaneous Head and Neck CancerGina D JeffersonMovement Disorders : Official Journal of the Movement Disorder Society|January 1, 1986
Preservation of the substantia nigra and locus coeruleus in a patient receiving levodopa (2 kg) plus decarboxylase inhibitor over a four-year periodN Quinn, D Parkes, I Janota, et al.Neurologia (Barcelona, Spain)|July 1, 1989
[Pharmacologic, surgical and infiltration of botulin toxin treatment in blepharospasm]F Grandas, J Elston, N Quinn, et al.Neuroscience|November 1, 1983
Alterations in cerebral dopamine function caused by administration of cis- or trans-flupenthixol for up to 18 monthsK Murugaiah, A Theodorou, P Jenner, et al.European Journal of Pharmacology|October 6, 1987
Pilocarpine-induced purposeless chewing behaviour in rats is dependent on intact central stores of 5-HTB Stewart, S Rose, P Jenner, et al.Movement Disorders : Official Journal of the Movement Disorder Society|January 1, 1991
Paroxysmal dystonic head tremorA J Hughes, A J Lees, C D MarsdenMovement Disorders : Official Journal of the Movement Disorder Society|March 26, 1999
The vulnerability of nigral neurons to Parkinson's disease is unrelated to their intrinsic capacity for dopamine synthesis: an in situ hybridization studyA E Kingsbury, C D Marsden, O J FosterYonsei Medical Journal|May 19, 2000
The pedunculopontine nucleus: its role in the genesis of movement disordersM S Lee, J O Rinne, C D MarsdenPageof 82